Can a 10-year-old patient on 18mg of Strattera (atomoxetine) be increased to 36mg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Strattera Dose Increase from 18mg to 36mg in a 10-Year-Old

Yes, you can increase from 18mg to 36mg, but this represents a doubling of the dose which is more aggressive than standard titration—a more conservative approach would be to increase to 25mg or 30mg first, then reassess after 1-2 weeks before advancing to 36mg if needed. 1

Standard Dosing Algorithm for Atomoxetine in Children

Target dosing for atomoxetine in children is 1.2 mg/kg/day, which can be administered once daily or divided into two doses. 2

  • For a typical 10-year-old weighing approximately 30-35 kg, the target dose would be 36-42 mg/day 1
  • The current dose of 18mg is below the typical therapeutic target for most children in this age range 2
  • Atomoxetine demonstrates dose-proportional increases in plasma exposure, meaning doubling the dose will approximately double drug levels 3

Recommended Titration Strategy

The safest approach is stepwise dose escalation rather than doubling:

  • Start with smaller incremental increases (e.g., 18mg → 25mg → 30mg → 36mg) over 1-2 week intervals 1
  • Monitor for adverse effects at each dose level, particularly gastrointestinal symptoms (nausea, abdominal pain), decreased appetite, and somnolence 1, 2
  • Assess symptom improvement using standardized rating scales (ADHD-RS or Conners scales) from both parents and teachers before each dose adjustment 4

Critical Monitoring Parameters

Check the following at baseline, 1 week after dose change, and with subsequent adjustments:

  • Heart rate and blood pressure (atomoxetine causes modest increases in both parameters) 1, 5
  • Appetite and weight (decreased appetite is common, though long-term growth effects normalize) 1, 2
  • Mood changes or suicidal ideation (black-box warning for increased suicidal thoughts in pediatric patients) 1

Pharmacokinetic Considerations

CYP2D6 metabolizer status significantly affects atomoxetine levels:

  • Extensive metabolizers (most patients) have a half-life of 5.2 hours and clearance of 0.35 L/h/kg 3
  • Poor metabolizers (7-10% of population) have a half-life of 21.6 hours and 10-fold higher steady-state concentrations 3
  • If this patient is a poor metabolizer (unknown unless tested), the 36mg dose could result in disproportionately high drug levels 3
  • Consider more conservative titration if the patient experienced significant side effects at 18mg, as this may indicate poor metabolizer status 1

Common Pitfalls to Avoid

  • Avoid rapid dose escalation without adequate monitoring period—give at least 1-2 weeks at each dose level to assess both efficacy and tolerability 1
  • Don't ignore cardiovascular monitoring—while increases in heart rate and blood pressure are typically modest and well-tolerated, they require documentation 5
  • Don't forget to obtain teacher ratings—school performance is a critical outcome measure and home ratings alone are insufficient 4

Duration of Action Advantage

Atomoxetine provides all-day coverage with once-daily morning dosing, extending through evening hours and into the next morning, which is particularly valuable for homework completion and morning routines. 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.